دورية أكاديمية

Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.

التفاصيل البيبلوغرافية
العنوان: Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
المؤلفون: da Rosa R; Graduate Program in Pharmacy, Pharmaceutical and Medicinal Chemistry Laboratory, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Zimmermann LA; Graduate Program in Pharmacy, Pharmaceutical and Medicinal Chemistry Laboratory, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., de Moraes MH; Protozoology Laboratory, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Schneider NFZ; Applied Virology Laboratory, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Schappo AD; Graduate Program in Pharmacy, Pharmaceutical and Medicinal Chemistry Laboratory, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Simões CMO; Applied Virology Laboratory, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Steindel M; Protozoology Laboratory, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Schenkel EP; Graduate Program in Pharmacy, Pharmaceutical and Medicinal Chemistry Laboratory, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil., Bernardes LSC; Graduate Program in Pharmacy, Pharmaceutical and Medicinal Chemistry Laboratory, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-900 SC, Brazil. Electronic address: l.bernardes@ufsc.br.
المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Nov 01; Vol. 28 (20), pp. 3381-3384. Date of Electronic Publication: 2018 Aug 31.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Elsevier Science Ltd
Original Publication: Oxford ; New York : Pergamon Press, c1991-
مواضيع طبية MeSH: Antiviral Agents/*pharmacology , Isoxazoles/*pharmacology , Sulfonamides/*pharmacology , Trypanocidal Agents/*pharmacology, Animals ; Antiviral Agents/chemical synthesis ; Antiviral Agents/chemistry ; Antiviral Agents/toxicity ; Cell Line, Tumor ; Cell Survival/drug effects ; Chlorocebus aethiops ; Humans ; Isoxazoles/chemical synthesis ; Isoxazoles/chemistry ; Isoxazoles/toxicity ; Leishmania/drug effects ; Molecular Structure ; Simplexvirus/drug effects ; Structure-Activity Relationship ; Sulfonamides/chemical synthesis ; Sulfonamides/chemistry ; Sulfonamides/toxicity ; Trypanocidal Agents/chemical synthesis ; Trypanocidal Agents/chemistry ; Trypanocidal Agents/toxicity ; Trypanosoma cruzi/drug effects ; Vero Cells
مستخلص: In this study we report the synthesis, characterization, biological evaluation, and druglikeness assessment of a series of 20 novel isoxazolyl-sulfonamides, obtained by a four-step synthetic route. The compounds had their activity against Trypanosoma cruzi, Leishmania amazonensis, Herpes Simplex Virus type 1 and cytotoxicity evaluated in phenotypic assays. All compounds have drug-like properties, showed low cytotoxicity and were promising regarding all other biological activities reported herein, especially the inhibitory activity against T. cruzi. The compounds 8 and 16 showed significant potency and selectivity against T. cruzi (GI 50  = 14.3 µM, SI > 34.8 and GI 50  = 11.6 µM, SI = 29.1, respectively). These values, close to the values of the reference drug benznidazole (GI 50  = 10.2 µM), suggest that compounds 8 and 16 represent promising candidates for further pre-clinical development targeting Chagas disease.
(Copyright © 2018 Elsevier Ltd. All rights reserved.)
فهرسة مساهمة: Keywords: Herpes Simplex Virus; Isoxazole; Leishmania amazonensis; Sulfonamide; Trypanosoma cruzi
المشرفين على المادة: 0 (Antiviral Agents)
0 (Isoxazoles)
0 (Sulfonamides)
0 (Trypanocidal Agents)
تواريخ الأحداث: Date Created: 20180909 Date Completed: 20190603 Latest Revision: 20191210
رمز التحديث: 20240829
DOI: 10.1016/j.bmcl.2018.08.040
PMID: 30194008
قاعدة البيانات: MEDLINE
الوصف
تدمد:1464-3405
DOI:10.1016/j.bmcl.2018.08.040